News summarySEC EDGARNov 2, 2026, 12:00 PM
IDEXX Laboratories, 8-K (2.02, 9.01): reported results of operations
IDEXX Laboratories reported third-quarter 2026 revenue of $1.214 billion, up 10%, and diluted EPS of $4.01, up 18% as reported, and raised its 2026 revenue guidance to $4.741 billion–$4.767 billion and EPS outlook to $14.96–$15.16.